Background illustration for clinical trials search

Paid Clinical Trials Toronto

Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer,
Location: Toronto, Hamilton, Buffalo NY, Cleveland OH, Detroit MI,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06343402

Phase 1, Recruiting

KRT-232 and TKI Study in Chronic Myeloid Leukemia

for
Chronic Myeloid Leukemia
Location: Toronto, Pittsburgh PA, Milwaukee WI, Augusta GA,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04835584

Phase 1, Phase 2, Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,
Location: Toronto, London, Cleveland OH, Windsor, North Canton OH,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase 3, Recruiting

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Female

Age: 18+

Code: NCT05065021

Phase 2, Recruiting

Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma

for
Classical Hodgkin Lymphoma, Relapsed Cancer, Refractory Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04510636

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)

for
Chronic Graft-versus-Host-Disease,
Location: Toronto, Saint Louis MO, Omaha NE, Portland OR
Sponsor: University of British Columbia

Sex: All

Age: 18+

Code: NCT05692713

Recruiting

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

for
Advanced Solid Tumor
Location: Toronto, Pittsburgh PA, Montreal, Columbus OH,
Sponsor: Senhwa Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT04890613

Phase 1, Recruiting

Study of Biomarkers in Gynecological Cancers

for
Gynecologic Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT03420118

Recruiting

A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors

for
Triple Negative Locally Advanced Non-resectable Breast Cancer,
Location: Toronto, Columbus OH, Boston MA, Nashville TN,
Sponsor: Marengo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06827613

Phase 1, Phase 2, Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

for
Advanced Solid Tumors, HER2 Mutation
Location: Toronto, Cleveland OH, Boston MA, Nashville TN,
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06760819

Phase 2, Recruiting

Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL

for
Relapsed or Refractory CD19+ B-cell Lymphoma,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05963217

Phase 1, Recruiting

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Toronto, Buffalo NY, Hackensack NJ, New York NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06121843

Phase 1, Recruiting

A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.

for
Advanced Solid Tumors Cancer, MSI-H Cancer
Location: Toronto, Maumee OH, Fairfax VA, Charlottesville VA,
Sponsor: Nimbus Wadjet, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06898450

Phase 1, Phase 2, Recruiting

Cabozantinib to Treat Recurrent Liver Cancer Post Transplant

for
Hepatocellular Carcinoma, Recurrent Cancer, Liver Transplant
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04204850

Phase 2, Recruiting

A Study of Head and Neck MRI and Tumor Microenvironment Biomarkers

for
Squamous Cell Carcinoma of Head and Neck
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06085781

Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for
Low Grade Serous Ovarian Cancer
Location: Toronto, Cleveland OH, Detroit MI, Pittsburgh PA,
Sponsor: Verastem, Inc.

Sex: Female

Age: 18+

Code: NCT06072781

Phase 3, Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

for
High-grade Serous Ovarian Carcinoma (HGSOC),
Location: Toronto, Montreal, Hackensack NJ, Vancouver,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06476808

Phase 1, Recruiting

Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasm
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05074355

Phase 2, Recruiting

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

for
Advanced Solid Tumor, Cutaneous Tumor, Subcutaneous Tumor,
Location: Toronto, Pittsburgh PA, Bethesda MD, Boston MA,
Sponsor: Ankyra Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06171750

Phase 1, Recruiting

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

for
Advanced Melanoma
Location: Toronto, Detroit MI, Pittsburgh PA, Columbus OH,
Sponsor: Immunocore Ltd

Sex: All

Age: 18+

Code: NCT06112314

Phase 3, Recruiting